- Home
- KURA vs NIE Comparison
KURA vs NIE Comparison
Compare KURA & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | NIE |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.0M | 704.1M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | KURA | NIE |
|---|---|---|
| Price | $8.64 | $24.19 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $26.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 43.4K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.04% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $124.03 | N/A |
| Revenue Next Year | $28.63 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $5.41 | $18.54 |
| 52 Week High | $12.49 | $26.00 |
Technical Indicators
Market Signals| Indicator | KURA | NIE |
|---|---|---|
| Relative Strength Index (RSI) | 48.03 | 32.17 |
| Support Level | $7.99 | $23.89 |
| Resistance Level | $10.50 | $24.47 |
| Average True Range (ATR) | 0.41 | 0.35 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 45.83 | 10.92 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.